Repurposing piroxicam for antithrombotic and cardiopulmonary protection: Pharmacological rationale and therapeutic potential [0.03%]
吡罗昔康的药理学原理和治疗潜力再利用以对抗血栓形成和心肺保护
Waseem Khalid,Arif-Ullah Khan
Waseem Khalid
Background: Recent research indicates that non-steroidal anti-inflammatory drugs may interfere in coagulation process and platelet aggregation. However, the potential of piroxicam in thrombotic and cardiopulmonary disorde...
Cytotoxic screening for three extracts of two plants using MTT assay and flow cytometric techniques [0.03%]
二种植物的三种提取物对肿瘤细胞的毒性筛查MTT及FCM法
Aimun A E Ahmed
Aimun A E Ahmed
Objectives: This study was set out to screen the cytotoxic activity of three extracts of two plants against three cancer cell lines. Methods: ...
Discovery of the protective effect of glutamine on acute alcoholic liver injury [0.03%]
谷氨酰胺对急性酒精性肝损伤保护作用的发现
Huan Yang,Wei Guo,San-Qiang Li et al.
Huan Yang et al.
Objective: Our research aims to evaluate the important role of glutamine (Gln) in alcohol (ethanol)-induced liver damage. Materials and methods: ...
Emerging patterns, impact, and collaborative networks of global scientific output on carrageenan and digestive problems: A bibliometric analysis [0.03%]
全球科学文献中关于角叉菜胶和消化问题的研究模式、影响及合作网络的计量学分析
Fran Espinoza-Carhuancho,Miguel Cabanillas-Lazo,Lucia Quispe-Tasayco et al.
Fran Espinoza-Carhuancho et al.
Background: The study aimed to analyze the current trends and spatiotemporal dynamics of research on carrageenan and digestive problems through a bibliometric study from 2019 to 2024. ...
Nutraceutical market in India: Thoughts on a right-based regulatory approach [0.03%]
印度的保健食品市场：基于权利的监管方法的思考
G Haripriya,P C Harigovind,Uma V Sankar
G Haripriya
The nutraceuticals industry in India has witnessed strong growth, expanding at a CAGR of ~12%-15% in recent years (2020-2023), driven by rising health awareness, increasing disposable incomes, and demand for preventive healthcare. The marke...
Bikash Ranjan Meher,Archana Mishra
Bikash Ranjan Meher
The drug development process is lengthy and complex and Phase IV is a crucial phase within it. Phase IV studies are conducted after a drug has been approved by regulatory agencies to further evaluate its safety, efficacy, usefulness in spec...
Genetic and nongenetic factors affecting vancomycin population pharmacokinetics and pharmacodynamics: A systematic review [0.03%]
万古霉素人群药代动力学和药效学的遗传和非遗传影响因素：系统性综述
Dimas Adhi Pradana,Erlina Marfianti,Ari Wibowo
Dimas Adhi Pradana
Despite frequent vancomycin prescribing, achieving optimal therapeutic outcomes is challenging due to its complex pharmacokinetic (PK) and pharmacodynamic (PD) properties. Those characteristics are influenced by various parameters, includin...
Semaglutide in obesity and type 2 diabetes: A review of clinical trial evidence from 1 to 5 semaglutide treatment effect in people with obesity program [0.03%]
塞马グル타ミド在肥胖和2型糖尿病中的临床试验证据回顾：1至5年的疗效分析
Aastha Khanna,Vipin Kumar,Sahil Gola
Aastha Khanna
Obesity and type 2 diabetes mellitus (T2DM) are widespread health concerns that often coexist, contributing to increased cardiometabolic risks and premature death. Despite advancements in both lifestyle interventions and medical treatments,...
Rituparna Maiti,Archana Mishra,Debasish Hota
Rituparna Maiti
Valproate-induced hyperammonemic delirium in a patient with bipolar affective disorder: A clinical caution [0.03%]
双相情感障碍患者出现丙戊酸诱导高氨血症性谵妄的临床警戒案例
Shruti Gupta,Sanyam Tyagi,Sumit Rana et al.
Shruti Gupta et al.